It has previously been suggested that patients with IBD should not be treated with oral iron due to the possibility of hepcidin-mediated iron malabsorption; however, studies have shown that even in inflammatory states, iron status is the primary determinant of hepcidin levels [[139], [140], [141], [142]]. This evidence concerns the gene HAMP and inflammatory bowel disease.